Naoero vs Saint Vincent and the Grenadines: New cases tested for RR-/MDR-TB
Naoero
100.0%
in 2023
Saint Vincent and the Grenadines
100.0%
in 2023
Naoero rank
1st
Saint Vincent and the Grenadines rank
1st
New cases tested for RR-/MDR-TB over time
- Naoero
- Saint Vincent and the Grenadines
How they compare
Naoero currently reports 100.0% against 100.0% in Saint Vincent and the Grenadines, a difference of 0.0%.
The two have swapped places 2 times across 9 shared years of data; in 2011 it was Saint Vincent and the Grenadines ahead.
Naoero ranks 1st and Saint Vincent and the Grenadines ranks 1st of 192 countries.
Saint Vincent and the Grenadines has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Naoero | Saint Vincent and the Grenadines | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.0% | 82.4% | 82.4% | Saint Vincent and the Grenadines |
| 2020s | 75.0% | 75.0% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Naoero or Saint Vincent and the Grenadines?
- Naoero, at 100.0% against 100.0% in Saint Vincent and the Grenadines as of 2023.
- What is the difference in new cases tested for rr-/mdr-tb between Naoero and Saint Vincent and the Grenadines?
- 0.0%, with Naoero ahead.
- How many years of comparable data are there for Naoero and Saint Vincent and the Grenadines?
- 9 years are reported by both, from 2011 to 2023.
- How do Naoero and Saint Vincent and the Grenadines rank globally for new cases tested for rr-/mdr-tb?
- Naoero ranks 1st and Saint Vincent and the Grenadines ranks 1st of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.